This novel allosteric pocket regulates both enzymatic activity and pulmonary hemodynamic function of PDE5 thereby serving as a new therapeutic target for PAH treatment (Zhang et al., 2020). This evidence concerns the gene PDE5A and pulmonary arterial hypertension.